Data / Form D filings / SirnaMed Therapeutics Inc.
SirnaMed Therapeutics Inc.: Form D filing
SirnaMed Therapeutics Inc., a pharmaceuticals company in Sewickley, PA, filed a Form D with the SEC in 2024. The latest, on July 25, 2024, reports $1.3 million sold of a $1.5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1707 DAWN DR., Sewickley, PA, 15143
- Phone
- (412) 996-2530
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2031257
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 25, 2024 | New notice | $1,500,000 | $1,250,000 | $250,000 | 9 | Jul 10, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Phong Tran | Executive Officer | |
| Stanley Marks | Director | |
| Jing-Zhou Hou | Executive Officer, Director, Promoter | |
| Song Li | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Jul 22, 2024 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SirnaMed Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.